Results 61 to 70 of about 23,433 (212)

Purpuric targetoid eruption revealing disseminated mucormycosis

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Francisco Mano, João Teixeira
wiley   +1 more source

Risk of Acute Kidney Injury Associated With Nephrotoxic Burden in Hospitalized Patients: A Scoping Review

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 4, Page 891-904, April 2026.
Limited evidence exists synthesizing the risk of acute kidney injury (AKI) associated with the concomitant administration of multiple nephrotoxic drugs, and even less examining the concept of nephrotoxic burden. The objective of this scoping review was to (1) identify definitions of nephrotoxic burden; (2) methods used to quantify (use of calculations)
Wafa Alatawi   +6 more
wiley   +1 more source

Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis

open access: yesResearch and Reports in Tropical Medicine, 2019
Mohammad Reza Shirzadi1,21Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran; 2Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Science, Tehran, IranAbstract: The genus ...
Shirzadi MR
doaj  

Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report

open access: yesBMC Pharmacology and Toxicology, 2018
Background The use of isavuconazole is approved for the management of invasive aspergillosis and mucormycosis, only in adults, as no paediatric pharmacology studies have been reported to date.
Marjorie Cornu   +9 more
doaj   +1 more source

Anfotericina B forma liposómica: un perfil farmacocinético exclusivo. Una historia inacabada. [PDF]

open access: yes, 2012
Amphotericin B in its lipid formulation continues to be the reference drug in the treatment of systemic fungal infections despite the time elapse since the development of this compound.
Azanza, J.R. (José Ramón)   +1 more
core  

Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting? [PDF]

open access: yes, 2019
Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring.
Kenny, Claire   +2 more
core   +2 more sources

Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 4, April 2026.
ABSTRACT Immunocompromised individuals experience an impaired immune function due to conditions that might be either congenital or acquired over the course of their lives. Epidemiological studies often rely on clinical definitions which, in some cases, benefit from being translated into machine‐readable algorithms for application to electronic health ...
Judit Riera‐Arnau   +62 more
wiley   +1 more source

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis

open access: yesJournal of Parasitology Research, 2011
Background. Topical treatment of cutaneous leishmaniasis is an attractive alternative avoiding toxicities of parenteral therapy while being administered through a simple painless route.
Pouran Layegh   +6 more
doaj   +1 more source

Tumor shape pulmonary mucormycosis associated with sinonasal aspergillosis in a diabetic patient

open access: yesMedical Mycology Case Reports, 2018
Mucormycosis is a rare and life-threatening fungal infection of the Mucorales order occurring mainly in immunosuppressed patients. The most common forms are rhinocerebral but pulmonary or disseminated forms may occur.
Sophie Point   +9 more
doaj   +1 more source

Aspergillus endophthalmitis: Potential role for vitreous galactomannan testing?

open access: yesInternational Journal of Infectious Diseases, 2020
Eye damage during invasive aspergillosis is rarely described and biological diagnosis remains challenging. Here we report the case of a heart transplant recipient with ocular aspergillosis complicating disseminated aspergillosis.
Damien Dupont   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy